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Spinocerebellar ataxia type 3 is one of the polyglutamine (polyQ) diseases, which are caused by a CAG-repeat
expansion within the coding region of the associated genes. The CAG repeat speciﬁes glutamine, and the
expanded polyQ domain mutation confers dominant toxicity on the protein. Traditionally, studies have
focused on protein toxicity in polyQ disease mechanisms. Recent ﬁndings, however, demonstrate that the
CAG-repeat RNA, which encodes the toxic polyQ protein, also contributes to the disease in Drosophila.T o
provide insights into the nature of the RNA toxicity, we extracted brain-enriched RNA from ﬂies expressing
a toxic CAG-repeat mRNA (CAG100) and a non-toxic interrupted CAA/G mRNA repeat (CAA/G105) for micro-
array analysis. This approach identiﬁed 160 genes that are differentially expressed speciﬁcally in CAG100
ﬂies. Functional annotation clustering analysis revealed several broad ontologies enriched in the CAG100
gene list, including iron ion binding and nucleotide binding. Intriguingly, transcripts for the Hsp70 genes,
a powerful suppressor of polyQ and other human neurodegenerative diseases, were also upregulated. We
therefore tested and showed that upregulation of heat shock protein 70 mitigates CAG-repeat RNA toxicity.
We then assessed whether other modiﬁers of the pathogenic, expanded Ataxin-3 polyQ protein could also
modify the CAG-repeat RNA toxicity. This approach identiﬁed the co-chaperone Tpr2, the transcriptional
regulator Dpld, and the RNA-binding protein Orb2 as modiﬁers of both polyQ protein toxicity and CAG-
repeat RNA-based toxicity. These ﬁndings suggest an overlap in the mechanisms of RNA and protein-
based toxicity, providing insights into the pathogenicity of the RNA in polyQ disease.
INTRODUCTION
A large number of neurodegenerative diseases are caused by
unstable trinucleotide repeat expansions in the associated
genes (1). Based on pathogenic mechanisms, these disorders
are categorized into different groups, including loss of
protein function, RNA toxicity and dominant protein-based
toxicity. Myotonic dystrophy type 1 (DM1) and myotonic dys-
trophy type 2 (DM2) are thought to be caused primarily by a
gain-of-function RNA toxicity. CUG and CCUG RNA expan-
sions in the non-coding regions of the dystrophia myotonica-
protein kinase (DMPK) gene and the zinc ﬁnger 9 (ZNF9)
gene cause DM1 and DM2, respectively (2). Polyglutamine
(polyQ) diseases are dominantly inherited disorders expanded
CAG repeats within the coding region of the associated genes,
such as Huntington’s disease (HD) and the spinocerebellar
ataxias (SCA1, 2, 3, 6, 7 and 17) (3). A pathological hallmark
of these diseases is ubiquitinated nuclear inclusions (NIs) con-
taining chaperones and subunits of the proteasome (3).
The prevailing hypothesis for polyQ disease mechanisms is a
protein effect due to the polyQ. Upregulating chaperones sup-
presses toxicity and supports the hypothesis that protein mis-
folding or aberrant interactions of the mutant protein cause
disease (4). Therefore, studies have traditionally focused on
protein-based mechanisms of toxicity conferred by the
expanded polyQ domain. Recent studies, however, suggest
that RNA toxicity is a component of degeneration (5). The
toxicity of a pathogenic, expanded polyQ Ataxin-3 protein in
Drosophilaissigniﬁcantlyreducedbyinterruptingthetypically
pure CAG-repeat sequence encoding the polyQ domain, with a
CAA-interrupted repeat which also encodes glutamine.
CAG-repeat RNA forms a hairpin structure which is thought
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CAA codons are predicted to disrupt the hairpin structure (8).
Furthermore, evidence suggests that pure or interrupted
CAG-repeat expansions in ATAXIN-2 (ATXN2) are associated
with distinct effects (9–12). Expanded pure CAG repeat in
ATXN2 typiﬁes SCA2. CAA interruptions in ATXN2 are found
in CAG-repeat expansions that present with parkinsonism or
amyotrophiclateralsclerosis(ALS).Takentogether,theseﬁnd-
ings suggest a role of the CAG-repeat RNA in toxicity and
effects. Additional studies indicate that simply a non-coding
RNA bearing only an abnormally long CAG repeat but not
coding for a protein can induce progressive neuronal dysfunc-
tion, including shortened lifespan and locomotor defects (5).
Interestingly, muscleblind (mbl), an RNA-binding protein
implicated as a modiﬁer in DM1, can dramatically enhance
the toxicity of both the Ataxin-3 protein and non-coding
CAG-repeat RNA in Drosophila (13,14). These ﬁndings
suggest that the CAG-repeat RNA, in the absence of coding
for a protein, may be a component of toxicity in polyQ
disease. However, mechanisms of CAG-repeat RNA toxicity
remain unclear.
To further understand mechanisms of CAG-repeat RNA
toxicity, we assessed transcriptional changes in ﬂies expres-
sing toxic expanded CAG-repeat RNA using microarray ana-
lysis in Drosophila. This approach identiﬁed transcriptional
changes in 160 genes speciﬁcally in the brain of ﬂies expres-
sing toxic CAG repeats, suggesting a robust component of
transcriptional alterations. These ﬁndings led us to test the
overlap between modiﬁers deﬁned for protein-based polyQ
toxicity and the toxicity of the non-coding RNA. Our ﬁndings
highlight an overlap between the two situations, suggesting a
component of shared mechanism.
RESULTS
Deﬁning gene expression changes in response to a toxic
non-coding CAG-repeat RNA
To identify gene pathways involved in response to a toxic non-
coding CAG-repeat RNA, we performed microarray analysis
on Drosophila brains using the Affymetrix Drosophila
Genome 2.0 Array. In order to assess early transcriptional
changes and to avoid detecting secondary responses, pre-
symptomatic adult ﬂies expressing a CAG repeat in the 3′ un-
translated region (3′-UTR) of a transgene encoding the control
protein DsRed were used (Fig. 1A). The control CAG0 ﬂies
express a DsRed reporter gene with no CAG repeat in the
3′-UTR. The CAG100 and CAG250 ﬂies have a CAG repeat
of about 100 and 250 CAG trinucleotides in the 3′-UTR, as
previously described (5). The CAA/G105 ﬂies are a non-toxic
trinucleotide control and express DsRed with an interrupted
CAA/CAG-repeat sequence in the 3′-UTR. The experimental
design is illustrated in Figure 1B. To deﬁne genes whose
expression is altered in response to a toxic CAG-repeat
RNA, we compared CAG100 ﬂies with age-matched ﬂies
expressing CAG0. To exclude transcriptional changes in
response to a non-toxic trinucleotide repeat, a second gene
list was generated by comparing CAA/G105 ﬂies with age-
matched CAG0 ﬂies. To then focus on the list of genes speciﬁc
to the toxic CAG-repeat RNA, we eliminated genes that were
differentially expressed in common to both CAG100 and
CAA/G105 ﬂies. At 3 days, ﬂies expressing CAG100 in all
neurons of the brain with elav-GAL4 driver show normal
climbing ability and normal survival compared with age-
matched control ﬂies expressing CAG0 (5). Fly brains were
thus dissected from 3-day animals, and RNA was isolated
for microarray analysis (Fig. 1C). To assess whether the
brain dissection enriched for brain RNAs, the dissection
quality was assessed by determining the relative level of ex-
pression of an eye gene, chaoptin (chp), which is selectively
expressed in photoreceptor cells, and the neural gene marker
amyloid precursor protein like (appl), which is selectively
expressed in neurons thus enriched in brain compared with
eye tissue (15,16). Quantitative real-time polymerase chain re-
action (qRT-PCR) analysis indicated that the relative expres-
sion level of chp was signiﬁcantly low (less than 10-fold
compared to head RNA) in all samples, whereas the level of
appl was enriched more than 12-fold compared with head
RNA (Fig. 1D and E). This analysis thus indicated that dissec-
tion of the brain from the eyes successfully enriched for RNA
expressed in the brain among the four independent replicates
of the microarray analysis.
The expression levels of each trinucleotide repeat transgene
were also controlled. Transcript levels were determined by
assessing the level of the DsRed portion of the transgenes
by qRT-PCR. The transgenes were adjusted to match at the
mRNA expression level, such that CAG0 ﬂies had one copy
of the transgene and the CAG100 ﬂies had ﬁve copies. The
CAA/G105 line expressed the transgene at levels lower than
those of the CAG100. Thus, we used two copies of this trans-
gene in order to express this RNA at a level at least as high as
that of the CAG100 ﬂies (Fig. 1F).
Global analysis of genes differentially expressed in ﬂies
expressing a toxic CAG RNA
Genes differentially expressed in CAG100 and/or CAA/G105
were deﬁned by comparing RNA from brains of ﬂies expres-
sing CAG100 versus CAG0 and CAA/G105 versus CAG0.
Pearson’s correlation coefﬁcient showed a strong correlation
between the biological replicates of any one transgene
(r . 0.99). We predicted that the transcriptional proﬁle of
CAA/G105 ﬂies would be more similar to CAG0 ﬂies than
to CAG100 ﬂies, because the interrupted CAA/G105 repeat
is not toxic. Hierarchical clustering conﬁrmed a higher simi-
larity between the transcriptional proﬁles of CAG0- and
CAA/G105-expressing ﬂies than between CAG0- and
CAG100-expressing ﬂies (Fig. 2A). In addition, it further sup-
ported our experimental design to exclude genes differentially
expressed in response to a long trinucleotide repeat by using
the interrupted CAA/G105 RNA.
About 129 transcripts were identiﬁed that were 2-fold or
greater upregulated and 81 that were 2-fold or greater
downregulated in CAG100 ﬂies compared with CAG0 ﬂies
(Fig. 2B). Among these, 19% (25 transcripts) upregulated
and 31% (25 transcripts) downregulated transcripts were also
differentially up- or downregulated in CAA/G105 ﬂies (Sup-
plementary Material, Table S1a). These transcripts were not
pursued at this time; these transcripts might reﬂect a general
response to expressing a long trinucleotide repeat RNA,
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down) were altered selectively in CAG100 ﬂies (Supplemen-
tary Material, Table S1b). About 122 transcripts (48 up and
74 down) were altered in CAA/G105 ﬂies, although not in
CAG100 ﬂies (Supplementary Material, Table S1c). To
verify the microarray analysis, we selected 12 genes of a
range of gene expression alterations to assess for expression
changes by qRT-PCR in CAG100 ﬂies (Supplementary Mater-
ial, Table S2). Five out of 12 genes expression changes, or
42%, were positively validated in CAG100 (P , 0.05).
Genes for which the expression level was not changed in a sig-
niﬁcant manner still showed a trend consistent with the micro-
array analysis. Eleven out of 12 genes expression changes, or
92%, were positively correlated with the change detected in
the microarray.
Gene Ontology (GO) analysis based on the Database of
Annotation, Visualization and Integrated Discovery was
performed to provide insights into the biological processes
affected by the genes differentially expressed selectively in
CAG100 ﬂies (Supplementary Material, Table S1b) (17,18).
We used the GO_FAT category which ﬁlters out very broad
GO terms to identify statistically enriched functional groups.
Several broad GO terms were enriched, including iron ion
binding, nucleotide binding and oxidation reduction (Fig. 3).
Genes related to ion channels and receptors were also affected
in response to CAG100. Trpgamma of the transient receptor
potential (TRP) classic channel family and CG34123 of the
TRP melastatin-like channel family were upregulated in
CAG100 ﬂies (2.4-fold change). TRP channels are essential
for the control of extracellular magnesium levels (19).
RNA-binding proteins are especially interesting targets for
potential mechanisms of CAG-repeat RNA toxicity. The tran-
scripts of two RNA-binding protein genes were downregulated
in CAG100 ﬂies: RNA-binding protein 4 (22.4-fold change),
which has an RNA recognition motif (RRM), and CHKov1
(22.3-fold change), predicted to have an RNA-binding motif
Figure 1. Microarray analysis with brain-enriched RNA. (A) DNA constructs with untranslated CAG or CAA/G repeats placed in the 3′-UTR of a control protein
DsRed. The control CAG0 ﬂies express the control DsRed reporter with no CAG repeat in the 3′-UTR. The CAG100 and CAG250 ﬂies express the DsRed
reporter with repeats of about 100 and 250 CAGs in the 3′-UTR (5). CAA/G105 ﬂies, a non-toxic trinucleotide control, express the DsRed reporter with a tri-
nucleotide sequence of CAA and CAG of 105 units (5). (B) Venn diagram illustrates the rationale to generate lists of genes differentially expressed in CAG100
animals selectively. (C) Illustration of brain dissection process, to enrich for RNA expressed in the brain tissue. The dissection removes the eyes and the outer
retinal lamina from the head capsule. (D and E) To verify the brain dissection quality, we quantiﬁed relative expression levels of (D) chaoptin (chp) and (E) appl
by qRT-PCR. (D) The gene chp is expressed in the retina. Quantifying its expression in brain, compared with head in all the preparations, indicated a lack of eye
tissue in the brain preparations. (D) The gene appl is selectively expressed in neurons and showed an enrichment in the brain preparations. (F) The expression
levels of each trinucleotide repeat transgene were also controlled. Transcript levels were determined by assessing the level of the DsRed portion of the transgenes
by qRT-PCR. Expression levels in (D–F) are relative to CAG0 (brain CAG0 was set to 1) and are presented as mean+SD (n ¼ 4 biological replicates used in
the microarray analysis). Genotypes of ﬂies from left to right: elav-GAL4 in trans to (CAG0) UAS-DsRed-CAG0, (CAG100) UAS-DsRed-CAG100 (5×), (CAA/
G105) is UAS-DsRed-CAA/G105 (2×).
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list of upregulated transcripts, expression of the RNA-binding
protein eIF4E-5 was upregulated 4.9-fold in CAG100 ﬂies.
The cytochromeP450 superfamily (Cyp) isa large and diverse
group of enzymes that catalyse oxidation. Of these, four cyto-
chrome P450-related genes were downregulated and four were
upregulated.Theirdifferentialexpressionmightreﬂectadetoxiﬁ-
cation response in CAG100 ﬂies at the pre-symptomatic stage.
Signiﬁcant upregulation of cytochrome P450-related genes has
also been observed in the microarray analysis of a Drosophila
model of Parkinson’s disease (PD) (20).
Hsp70, a genetic modiﬁer of polyQ toxicity, is upregulated
in microarray analysis
Intriguingly, in the microarray analysis, we found that some of
the Hsp70 genes were signiﬁcantly upregulated in brains of
animals expressing the toxic CAG100 RNA (Supplementary
Material, Table S1b). Heat shock protein 70 (Hsp70) is a
powerful modulator of the pathogenic polyQ protein, such
that in Drosophila models for SCA3, Hsp70 becomes loca-
lized to the NIs (4). Furthermore, upregulation of Hsp70 sup-
presses polyQ-mediated neurodegeneration. There are
multiple copies of the Hsp70 genes in Drosophila at distinct
loci, including Hsp70Aa and Hsp70Ab at chromosomal pos-
ition 87A and Hsp70Ba, Hsp70Bb, Hsp70Bbb and Hsp70Bc
at 87B. We found that probe sets of transcripts for Hsp70Ba,
Hsp70Bb and Hsp70Bbb genes were upregulated 4.06-fold.
Given this upregulation of Hsp70 transcripts, we used a
second technique to determine whether abnormal localization
or levels of Hsp70 protein were detectable in ﬂies expressing
CAG100. Tissue immunostaining of ﬂy brains using an anti-
body that detects the Hsc70/Hsp70 protein family was per-
formed on ﬂies expressing the toxic RNA repeat (Fig. 4A).
At 3 days, when an Hsp70 transcriptional change was detect-
able by the microarray analysis, we did not see an alteration of
the Hsc70/Hsp70 protein in CAG100 ﬂies compared with con-
trols (Fig. 4C and D). By 28 days, the brain normally shows a
Figure 2. Transcriptional proﬁles of CAG100 and CAA/G105 ﬂies. (A)A
total of four independent biological replicates were examined by microarray
analysis. Hierarchical clustering of all elements on the array by Euclidean dis-
tance showed a higher similarity between transcriptional proﬁles of the same
genotypes, regardless of the replicate. Hierarchical clustering also showed a
higher similarity between the transcriptional proﬁles of CAG0 and CAA/
G105 than between CAG0 and CAG100. (B) Venn diagram highlighting the
number of differentially expressed genes that have at least a 2-fold change
in CAG100- and/or CAA/G105-expressing ﬂies (step-up P , 0.05).
Figure 3. Analysis of GO categories for genes differentially expressed in
CAG100. (A) Bar graph shows the GO terms and the number of genes in
each category that are signiﬁcantly enriched in the CAG100 gene list. The
enrichment score (E) is the P-value in the -log scale. The P-value shows
whether the gene list is speciﬁcally enriched in the corresponding annotation
cluster compared with random chance. The enrichment score is ≥1.3 (dashed
line) when the P-value is ≤0.05. (B) Lists of genes in each enriched category
in (A).
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ingly, immunostaining of CAG100-expressing animals
revealed abundant Hsc70/Hsp70 accumulations in the cortical
region of the brain at 28 days (Fig. 4E). Quantiﬁcation of the
accumulations (Fig. 4E′ and F′) showed that the number of
Hsc70/Hsp70 accumulations was signiﬁcantly increased
(P , 0.05) in CAG100-expressing ﬂies compared with
control animals (Fig. 4B). Thus, the microarray analysis
revealed a transcriptional increase in Hsp70 genes in
CAG100 ﬂies in 3-day pre-symptomatic animals and a
protein translational response in Hsc70/Hsp70 in 28-day
animals. Furthermore, these data suggested an overlap in the
biological response of the animal to the toxic expanded
polyQ protein and toxic expanded CAG-repeat RNA,
namely an Hsc70/Hsp70 response.
Hsp70 is a modiﬁer of Ataxin-3 protein-based
neurodegeneration and of CAG-repeat RNA-based toxicity
To determine whether upregulation of Hsp70 could modify the
toxicity of the CAG-repeat RNA, we co-expressed human
Hsp70 together with a non-coding CAG250 RNA ubiquitously
in the animal with daughterless-GAL4 (da-GAL4). CAG250
ﬂies express a sequence of 250 CAG trinucleotide repeats in
the 3′-UTR of the DsRed reporter. Flies expressing CAG250
showed a stronger toxicity than animals with tissue-speciﬁc
expression of the RNA, thus facilitating the analysis of modi-
ﬁer genes. When expressed in this manner, the CAG250 repeat
caused compromised climbing ability at day 1 that progres-
sively deteriorated over 14 days (Fig. 5A). Upregulation of
Hsp70 mitigated the toxic effects of the CAG250 repeat,
such that now 61+5% of the animals could climb at day 1,
compared with 38+7% in the absence of added Hsp70
(Fig. 5B). The effect of Hsp70 persisted with time such that
by 14 days, whereas normally only 12+7% of CAG250
ﬂies could climb, with co-expressed Hsp70, now 27+5% of
CAG250 ﬂies could climb. We conﬁrmed that Hsp70 had no
effect on the level of expression of the CAG250 repeat
(Fig. 5C); rather, added Hsp70 mitigated the toxic effects of
the CAG250 RNA. These data indicate that Hsp70 is a modu-
lator of both pathogenic polyQ protein-based toxicity and tox-
icity conferred by a non-coding expanded CAG-repeat RNA.
Figure 4. Hsc70/Hsp70 accumulated in aged CAG100 ﬂies. (A) Cryosection of a CAG100 ﬂy head at 28 days, immunostained for Hsc70/Hsp70. The dashed
outline represents the area enlarged in (C–F). (B) Graph of the mean number of Hsc70/Hsc70 particles in CAG0- and CAG100-expressing animals at 28 days.
The average number of Hsc70/Hsc70-positive particles within the area shown in (E′) and (F′) was quantiﬁed. Error bars represent SD (∗P , 0.05, Student’s t-test;
n ¼ 3–4). (C and D) At 3 days, Hsc70/Hsp70 accumulation is not detectable in CAG0 and CAG100 ﬂy brains. Enlarged images of the dashed outline area are
shown in (C′) and (D′) (green: anti-Hsc70/Hsp70, blue: DAPI). (E and F) At 28 days, there are prominent Hsc70/Hsp70 accumulations in CAG100 ﬂies. Enlarged
images of the dashed outline area are shown in (E′) and (F′). Genotypes of ﬂies: elav-GAL4 in trans to (CAG0) UAS-DsRed-CAG0 and (CAG100)
UAS-DsRed-CAG100 (5×). DAPI images are shown next to (C′–F′) for orientation.
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based toxicity raised the possibility that other modiﬁers of the
pathogenic polyQ protein-based toxicity may also affect CAG
RNA-based toxicity.
Additional modiﬁers of CAG-repeat RNA toxicity
identiﬁed from a targeted modiﬁcation screen
A previous genetic screen had identiﬁed a number of modiﬁers
of Ataxin-3 protein-associated neurodegeneration (21). We
therefore performed a targeted modiﬁcation screen of these
enhancer–promoter (EP)-element insertion lines for ability
to modulate the CAG-repeat RNA toxicity. To assess
effects, we examined several indicators of RNA-based toxicity
when a CAG250 repeat is expressed in the animal: wing
posture and motility deﬁcits. Normally, ﬂies hold their wings
ﬂat to the back, rarely showing an abnormal upward wing
posture (Fig. 6A). However, 70% of CAG250 ﬂies displayed
an abnormal wing posture, holding one or both wings up
(Fig. 6A and B). This abnormality may be due to muscle-
and/or neural-based effects. Previous ﬁndings also show that
ﬂies display defects in climbing ability when expressing the
toxic CAG-repeat RNA in neurons with elav-GAL4 (5)
(Fig. 5A). We used these two indicators of the toxicity of
the CAG250 RNA (held-up wings and loss of climbing
ability) to assess whether additional previously deﬁned modi-
ﬁers of Ataxin-3 protein-based toxicity could affect RNA tox-
icity.
Twenty-ﬁve different modiﬁers were previously isolated in
a genome-wide screen for suppressors or enhancers of patho-
genic polyQ Ataxin-3 protein toxicity (21). Of these, three
mitigated both the wing posture and locomotor defects of
CAG250 ﬂies: the co-chaperone Tpr2
EB7-1A, the lin-41 homo-
loguedpld
EP546andRNA-bindingproteinorb2
B8-S(Fig.6D–I).
While only 26+4% of CAG250 ﬂies had normal wing
posture, now 66+10% of ﬂies with upregulated Tpr2
showed normal wing position (Fig. 6D). Tpr2
EB7-1A also func-
tionallyrescuedtheclimbingdefectsofCAG250ﬂies(58+8%
of Tpr2
EB7-1A ﬂies could climb, whereas only 36+5% of
CAG250 ﬂies could climb in a similar manner in parallel
control experiments) (Fig. 6E). Upregulation of dpld with
the dpld
EP546 allele rescued both wing posture and locomotor
dysfunction, such that 58+9% of CAG250 ﬂies with upregu-
lated dpld
EP546 had normal wing posture, and climbing was
restored such that 62+9% of animals could climb (Fig. 6F
and G). Upregulation of orb2 with the orb2
B8-S allele resulted
in 80+14% of CAG250 ﬂies now showing normal wing
posture and 62+8% of animals climbing normally (Fig. 6H
and I). By qRT-PCR, we conﬁrmed that these modiﬁers did
not affect the expression levels of the CAG-repeat RNA
(Fig. 6C). Taken together, these data indicated that these
modiﬁers, originally identiﬁed as genes that when upregulated
can mitigate Ataxin-3 pathogenic protein-based toxicity, also
rescue CAG-repeat RNA-based toxicity.
The genetic screen for modiﬁers of Ataxin-3 protein toxicity
was performed with a transgene bearing a pure CAG-repeat
RNA. As these four modiﬁers could modulate both the toxic
effect of this transgene and the toxic effect of a non-coding
CAG-repeat RNA, we were interested in whether the mitiga-
tion of the Ataxin-3 toxicity was due to a selective effect on
the RNA versus an effect on both the protein and the RNA.
To address this, we determined whether interrupting the
RNA sequence of the Ataxin-3 pathogenic protein affected
the interaction with these modulators. If these modiﬁers
were no longer effective, then this would suggest that these
modiﬁers were directed solely to the CAG-repeat RNA. We
therefore co-expressed Hsp70, Tpr2
EB7-1A, dpld
EP546 and
orb2
B8-S, with an Ataxin-3-expressing transgene in which the
polyQ domain is encoded by a CAA/G-interrupted repeat se-
quence. The SCA3trQ78CAA/G transgene encodes a toxic
polyQ protein identical in sequence to the CAG-repeat
Figure 5. Hsp70 rescues climbing defects of CAG250 ﬂies. (A) Expressing
GFP or Hsp70 alone does not cause climbing defects. In contrast, expressing
CAG250 causes climbing defects in ﬂy, and this defect progress with age.
Genotypes of ﬂies: da-GAL4 in trans to (GFP) UAS-GFP, (Hsp70)
UAS-Hsp70 and (GFP+CAG250) is UAS-GFP UAS-DsRed-CAG250.( B)
Co-expression of Hsp70 with CAG250 suppresses CAG250 toxicity and
rescues climbing deﬁcits. The climbing ability of CAG250 ﬂies was examined
at days 1, 7 and 14. CAG250/Hsp70 ﬂies exhibit a signiﬁcant improvement in
climbing ability compared with age-matched CAG250 ﬂies (mean+SD, n ¼
3, Student’s t-test, ∗P , 0.05). Genotypes of ﬂies: da-GAL4 in trans to
(CAG250+GFP) UAS-DsRed-CAG250 UAS-GFP and (CAG250+Hsp70) is
UAS-DsRed-CAG250; UAS-Hsp70.( C) Levels of CAG-repeat RNA were
examined by qRT-PCR and were not signiﬁcantly altered when co-expressed
with Hsp70 (3-day ﬂies, Student’s t-test, P . 0.05). Genotypes of ﬂies from
left to right: da-GAL4 in trans to UAS-GFP UAS-DsRed-CAG250 and
UAS-DsRed-CAG250; UAS-Hsp70.
Human Molecular Genetics, 2011, Vol. 20, No. 24 4815encoding transgene SCA3trQ78CAG, differing only in whether
the RNA is a pure CAG or interrupted by CAA codons.
Expression of SCA3tr Q78CAA/G in the eye by gmr-GAL4
gave a disrupted eye effect (Fig. 7A), and co-expression of
these modiﬁers mitigated the toxicity (Fig. 7B–E). These
data indicate that these modiﬁers can modulate both
Ataxin-3 pathogenic protein-based toxicity and CAG-repeat
RNA-based toxicity, highlighting the overlap between RNA-
based and polyQ protein-based toxicity mechanisms.
DISCUSSION
PolyQ diseases have been considered toxic polyQ-based disor-
ders, although recent data suggest that the expanded CAG
Figure 6. Tpr2
EB7-1A, dpld
E546 and orb2
B-8S suppress CAG-repeat RNA toxicity. (A) Abnormal wing posture (one or both wings held-up, lower panels) is
observed in ﬂies expressing CAG250 with a ubiquitous driver da-GAL4. (B) About 30% of animals expressing CAG250 have abnormal wing posture at day
1. Genotypes of ﬂies from left to right: da-GAL4 in trans to UAS-GFP and UAS-GFP UAS-DsRed-CAG250.( C) Co-expression of Tpr2
EB7-1A, dpld
E546 and
orb2
B-8S, with CAG250 does not alter the CAG250 relative expression level examined by qRT-PCR (mean+SD, n ¼ 3, Student’s t-test, P . 0.05). (D, F
and H) Upregulation of Tpr2
EB7-1A, dpld
E546 and orb2
B-8S signiﬁcantly rescued abnormal wing posture of CAG250 ﬂies at day 1. (E, G and I) Co-expression
of Tpr2
EB7-1A, dpld
E546 and orb2
B-8S signiﬁcantly rescue climbing defects of CAG250 ﬂies at day 1 (mean+SD, n ¼ 3 independent experiments, Student’s t-test,
∗P , 0.05). Genotypes of ﬂies: da-GAL4 in trans to (CAG250+GFP) UAS-DsRed-CAG250 UAS-GFP, (CAG250+Tpr2
EB7-1A) UAS-DsRed-CAG250
Tpr2
EB7-1A, (CAG250+dpld
E546) UAS-DsRed-CAG250 dpld
E546 and (CAG250+orb2
B-8S) UAS-DsRed-CAG250; orb2
B-8S.
4816 Human Molecular Genetics, 2011, Vol. 20, No. 24trinucleotide repeat RNA encoding the polyQ domain may
contribute to the disease (5). Given that mechanisms of
RNA toxicity remain unclear, we provided insights into the
nature of the CAG-repeat RNA toxicity by performing a
microarray analysis to deﬁne the global transcriptional
proﬁle of the ﬂy brain upon expression of toxic trinucleotide
repeat RNA. These studies revealed that 160 genes were
altered, including the Hsp70 genes. A targeted genetic
screen then deﬁned Hsp70, as well as a number of other
genes, as modiﬁers of both the polyQ protein and toxic
CAG-repeat RNA. These data indicate an overlap between
mechanisms of the protein-based and RNA-based toxicities
that may contribute to polyQ disease.
Microarray analysis identiﬁes altered Hsp70: a modiﬁer of
CAG-repeat RNA-based toxicity
Our microarray analysis identiﬁed Hsp70 as upregulated in
CAG100 ﬂies. To conﬁrm these ﬁndings, we performed immu-
nostaining analysis for the Hsc70/Hsp70 protein in brains of
animalsexpressingthetoxicRNA.Thisrevealedage-dependent
accumulations. These data indicate that upregulated Hsp70
induced by the toxic CAG repeat occurs at both transcriptional
andtranslationallevels.GiventhatHsc70/Hsp70accumulations
are induced by expressing CAG100, and Hsp70 is a powerful
suppressor of several human neurodegenerative diseases, we
then performed functional analysis. These ﬁndings showed
that upregulation of Hsp70 rescues the locomotor dysfunction
caused by the toxic CAG repeat. Similarly, in a Drosophila
model of fragile X syndrome, which is also an RNA-mediated
neurodegenerative situation, upregulation of Hsc70 modiﬁes
the CGG-repeat RNA-induced effects (22). Taken together,
these data suggest that Hsc70/Hsp70 chaperones can modify
toxicity conferred by both pathogenic RNA and proteins.
Hsp70isthoughttopreventaggregationortoassistintherefold-
ing of misfolded protein. Possible mechanisms of suppression
by Hsp70 in RNA-mediated toxicity might involve a misfolded
protein response triggered by deleterious consequence of the
pathogenic repeat RNA.
Other ways in which Hsp70 may suppress include modula-
tion of death pathways (23). Notably, several genes associated
with the regulation of apoptosis were in the list of genes
affected in the CAG100 ﬂies. Upregulation of cytochrome c
transcript is a general early apoptotic response, and studies
show that Hsp70 suppresses apoptosis by acting downstream
of cytochrome c release in mammalian cells (24,25). Intri-
guingly, cytochrome c distal (Cyt-c-d), one of the Drosophila
cytochrome c genes, was upregulated pre-symptomatically in
CAG100 ﬂies in the microarray analysis (Cyt-c-d, 2.0-fold
change). Moreover, upregulation of Hsp70 suppresses the
symptomatic effects of toxicity of CAG250 ﬂies. Potentially,
Hsp70 may suppress RNA-based toxicity through modulation
of apoptosis processes as an additional mechanism.
ThemolecularchaperoneHsp70respondstoseveralneurode-
generative disease situations in animal models. In the
Drosophila model of SCA3, Hsp70 is localized to the nuclear
accumulations, whereas normally there is a low level of
Hsp70 in the cytoplasm (4). Upregulation of Hsp70 suppresses
the toxicity caused by the pathogenic Ataxin-3 protein. In
mouse models of spinal bulbar muscular atrophy (SBMA),
due to polyQ expansions in the androgen receptor gene,
Hsp70 levels are increased in the muscle, and upregulation of
Hsp70 ameliorates pathogenicity of the SBMA model (26). In
the Drosophila model of fragile X-associated tremor/ataxia
syndrome, Hsp70-containing inclusions are induced by expres-
sing long CGG repeats in the 5′-UTR of an enhanced green
ﬂuorescent protein (EGFP) reporter gene. Upregulation of
Hsc70 modiﬁes CGG-repeat-induced degeneration (22). RnrL,
which suppresses non-coding CTG112 RNA-induced neurode-
generation in a Drosophila model forSCA8, was also identiﬁed
in our present study (RnrL, 7.4-fold change) (27). These data
suggest that candidate genetic modiﬁers can be identiﬁed
through microarray analysis, deﬁning altered genes in the
disease-associated condition.
A recent study shows that modiﬁer of mdg4 [mod(mdg4)]
transcript levels is altered in Drosophila heads upon expres-
sion of CAG-, CUG- and AUUCU-repeat RNA and that
mod(mdg4) is an enhancer of CAG- and CUG-repeat toxicity
(28). We did not ﬁnd that mod(mdg4) met our criteria in gen-
erating gene lists; however, we used only brain tissue and not
heads with eye tissue included. Transcriptional proﬁles may
differ in distinct cell types in response to toxic elements,
and brain-enriched RNA may reveal distinct or more subtle
changes in gene expression that are selective to neurons.
Candidate targets for further investigation of RNA-based
toxicity mechanisms
Several functional classes of genes were differentially
expressed in CAG100 ﬂies (Fig. 3). These classes give insights
Figure 7. Hsp70, Tpr2
EB7-1A, dpld
E546 and orb2
B-8S suppress both CAG-repeat RNA-based toxicity and polyQ protein toxicity. (A) Eyes of ﬂies expressing
SCA3trQ78CAA/G, the toxic polyQ protein expressed from a transgene with an interrupted CAA/G polyQ repeat region, have degenerate eyes with reduced
pigmentation. (B–E) Upregulation of Hsp70, Tpr2
EB7-1A, dpld
E546 and orb2
B-8S ameliorates the degenerative effect of SCA3trQ78CAA/G. Genotypes of ﬂies
(A–E): gmr-GAL4 SCA3trQ78CAA/G in trans to +, UAS-Hsp70, Tpr2
EB7-1A, dpld
E546 and orb2
B-8S.
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RNA. For example, microglial activation and innate immune
system activation are recognized as a disease feature in Alz-
heimer’s (AD), PD, HD and ALS. Anti-inﬂammatory treat-
ments may reduce susceptibility to AD and PD (29).
Proteins involved in the innate immune response could be
used as molecular biomarkers to identify pre-symptomatic
stage of AD (30). Beyond changes in the cytochrome P450
superfamily, there were three upregulated transcripts asso-
ciated with innate immune response, including attacin,
Immune-induced molecule 2 and metchnikowin. These gene
lists not only provide candidate targets for further genetic ana-
lysis, but might also provide insights into potential
CAG-repeat RNA pathogenesis and the common characteristic
of neurodegenerative diseases. Furthermore, a set of genes was
selectively affected in CAA/G105 and not in CAG100 or
CAG0 (Supplementary Material, Table S1c). These transcripts
may be relevant to situations in which the polyQ repeat se-
quence in the disease gene is interrupted, as in ATXN2
polyQ expansions that present with parkinsonism or ALS
rather than SCA2. Future studies may reveal insights with
regard to potential pathways modulated.
Expanded CAG-repeat RNA and pathogenic polyQ protein
trigger common pathways
Beyond Hsp70, three genetic modiﬁers identiﬁed in the
present study, Tpr2
EB7-1A, dpld
EP546 and orb2
B8-S, also sup-
press both CAG-repeat RNA-based toxicity and polyQ
protein-based toxicity. Previous studies show that these modi-
ﬁers do not alter the Hsp70 expression level, thus function in a
distinct manner (21). dTPR2 is homologous to the human tet-
ratricopeptide repeat protein 2. Tpr2 is a co-chaperone con-
taining two chaperone-binding TPR domains and a DnaJ
homologous J domain (31,32). In previous studies, Hsp70
and ﬁve other modiﬁers of Ataxin-3 protein-associated neuro-
degeneration were categorized in the chaperone class (21).
Surprisingly, two of these six also suppressed CAG-repeat
RNA toxicity (Hsp70 and Tpr2
EB7-1A) (Fig. 8). This raises a
role for chaperones and ubiquitin-associated pathway compo-
nents in CAG-repeat toxicity, although likely speciﬁc genes
involved reﬂect speciﬁc processes primarily detected.
dpld
EP546 was previously identiﬁed as a strong suppressor of
Ataxin-3 toxicity and could suppress tau toxicity as well as a
cell-death gene (hid). Intriguingly, data indicate that the
mouse homologue of dpld (lin-41) is localized to P-granules,
which are sites of RNA processing and degradation (33).
This overlap between dpld as a modiﬁer of polyQ protein tox-
icity and the CAG-RNA-based toxicity, coupled with the
implication of P-granule involvement, supports the idea of
RNA pathways going awry in both situations.
Drosophila orb2 is also known as Drosophila cytoplasmic
polyadenylation element-binding protein (CPEB). CPEB
belongs to a family of RNA-binding proteins which have two
RRMs and aZn-ﬁngerdomain(34).CPEBsregulate translation
oftargetmRNAs(35)andfunctioninmanyprocesses,including
synaptic plasticity, learning and memory (36–38). Recent
studies show that Drosophila Orb2 binds directly to transcripts
associated with long-term memory, and Orb2 targets are asso-
ciated with neuronal growth, synapse formation and protein
turnover (39). Taken together, these studies indicate that Orb2
is broadly involved in various neuronal functions. Moreover,
Orb2isco-localized indFMR1-containing (fragile Xmentalre-
tardation 1) foci in cultured Drosophila primary neurons (40).
Fragile X mental retardation protein has been implicated in
the translational regulation of target mRNAs in neurons and is
the protein affected in fragile X syndrome (41–43). The
pathogenic role of neuronal RNA granules in neurological
disease suggests the possibility that CAG-repeat RNA might
interfere with the normal function of Orb2 in neuronal RNA
granules to cause toxicity. Homologues of mbl, which modiﬁes
Ataxin-3 protein toxicity, CAG-repeat RNA toxicity and
CUG-repeat RNA toxicity, co-localize with RNA stress gran-
ules in cell culture (44,45). Thus, mbl may be broadly involved
in other aspects of RNA metabolism that contribute to neurode-
generative disease. Future investigation to examine effects
of the CAG-repeat RNA, and neural granules and P-bodies,
together with studies of Orb2 will reveal further insight.
Intriguing recent data raise the possibility that expanded
repeat RNAs may support protein translation in a manner
not dependent on an AUG, as with classical protein-coding
genes. That is, the hairpin repeat structure of triplet-repeat
RNAs of a variety of sequences can lead to protein translation
of the repeat region in all three reading frames. This so-called
repeat-associated non-ATG translation (RAN translation) is
reported to occur with SCA8 and DM1 CAG expansion tran-
scripts (46). In the ﬂy, previous studies failed to detect a
protein generated by the non-coding CAG-repeat RNA (5);
however, these studies were performed on young animals.
Similarly, in a mouse model of CAG-repeat RNA toxicity, a
Figure 8. Modiﬁers of Ataxin-3 protein-associated neurodegeneration affect
both polyQ protein toxicity and CAG-repeat RNA-based toxicity. A previous
genetic screen identiﬁed a number of modiﬁers of Ataxin-3 protein-associated
neurodegeneration. We therefore performed a targeted screen of these modu-
lators for ability to affect the CAG-repeat RNA toxicity. Hsp70 and another
18 genes were identiﬁed as suppressors of Ataxin-3 protein-based neurodegen-
eration. Among these 19 modulators, Hsp70, Tpr2
EB7-1A, dpld
E546 and orb2
B8-S
were found in the present study to also affect the CAG-repeat RNA-based tox-
icity. Previous studies also demonstrated that mbl affects the toxicity of both
the Ataxin-3 protein and non-coding CAG-repeat RNA. These genes that can
modulate both polyQ protein and CAG-repeat RNA-based toxicities highlight
an overlap between RNA-based and polyQ protein based-toxicity mechanisms.
4818 Human Molecular Genetics, 2011, Vol. 20, No. 24polyQ-containing protein was not detected upon expression of
CAG repeats in the 3′-UTR of the EGFP gene (47). RAN,
however, may be selective to speciﬁc cell subtypes. Our
ﬁnding of accumulation of Hsc70/Hsp70 with age in
CAG-repeat expressing ﬂies, suggestive of late-onset
accumulation of misfolded protein, may be indicative of
such mechanisms, as is the overlap in modiﬁers of the protein-
based toxicity and RNA-based toxicity. Our studies provide a
foundation to address the extent to which this mechanism, as
well as others, contribution to the toxicity conferred by the
expanded repeat CAG-RNA, and its integration with protein-
based toxicity mechanisms.
MATERIALS AND METHODS
Drosophila stocks and crosses
General ﬂy lines were from Bloomington Drosophila Stock
Center and maintained at 258C on standard medium, unless
otherwise indicated. Transgenic lines UAS-DsRed-CAG0,
UAS-DsRed-CAG100, UAS-DsRed-CAG250, UAS-DsRed-
CAA/G105 and genetic modiﬁer EP insertion lines have been
described(5,21).ControlCAG0ﬂiesexpressatransgeneencod-
ingaDsRedreporterproteinwithnoCAGrepeatinthe3′-UTR.
CAG100 and CAG250 ﬂies express transgenes encoding the
DsRed reporter with repeats of approximately 100 and 250
CAGs in the 3′-UTR, as described previously (5). CAA/G105
ﬂies, a non-toxic trinucleotide control, express a transgene
encoding DsRed with a repeat sequence of CAA and CAG of
105 triplet codons in the 3′-UTR, as described (5).
RNA isolation
Four independent replicates of ﬂies expressing CAG0,
CAG100 or CAA/G105 by elav-GAL4 were raised at 258C
with 12 h/12 h light–dark cycle (5). Three-day female ﬂies
from four independent crosses were collected and brains dis-
sected. Fly brain tissue (about 20 brains per sample, dissected
from head capsule, eyes, lamina and outer medulla removed)
was isolated in cold phosphate-buffered saline and stored in
Trizol Reagent (Invitrogen, Carlsbad, CA) at 2808C. Total
brain RNA was extracted and puriﬁed using Trizol Reagent
(Invitrogen) and the RNeasy Mini system (Qiagen, Valencia,
CA) and treated with RNase-free DNase I (Qiagen). cDNA
ampliﬁcation (Ovation Pico WTA systems, NuGEN, San
Carlos, CA), labelling and hybridization (Encore Biotin
Module, NuGEN) were carried out by the microarray core fa-
cility at University of Pennsylvania.
Microarray analysis
Affymetrix Drosophila Genome 2.0 microarrays (Affymetrix)
were used for the microarray analysis. Normalization of
probe signal intensity levels across arrays was performed
using the GC robust multichip average algorithm implemented
in Partek Genomic suite 6.2 beta. Principle component analysis
and Pearson’s correlation coefﬁcient were used to reveal out-
liner samples. Three-way analysis of variance (ANOVA) con-
ﬁrmed that the source of variation was not due to different
batches of RNA. To generate lists of genes differentially
expressed in different conditions, CAG100 and CAG250
were compared with CAG0 at the corresponding age (step-up
P , 0.05). We used one-way ANOVA implemented in Partek
Genomic suite 6.2 beta to generate a list of differentially
expressed genes under each condition. Unannotated probe
sets were discarded. When multiple probe sets were assigned
to the same gene, the probe set with the smallest step-up
P-value was included. Gene lists were restricted to genes that
have at least a 2-fold change and step-up P-value less than
0.05. GEO accession number for the data is GSE31875.
Quantitative RT-PCR
qRT-PCR was performed on 3-day adult ﬂy brain RNA. Brain
dissections and total brain RNA were prepared and extracted,
asdescribedearlier.cDNAwassynthesizedusingtheHighCap-
acity cDNA reverse transcription kit (Applied Biosystems,
Foster City, CA, USA). qRT-PCR was performed using
SYBR Green master mix (Applied Biosystems). All RNA
samples were analysed in triplicate or quadruplicate using a
7500 Fast Real-Time PCR System (Applied Biosystems).
Data were analysed using the relative quantiﬁcation method.
The endogenous control was ribosomal protein 49 (Rp49).
Primers identiﬁed using Primer Express 2.0 (Applied Biosys-
tems) were synthesized by Integrated DNA Technologies, Inc.
Primer sets are as follows:
rp49 forward: 5′-CAACATCGGTTACGGATCGA-3′, rp49
reverse: 5′-AATCCGGTGGGCAGCAT-3′; Roe1 forward: 5′-
CCTAGTTTCTAAGAGATCTGTGACTG-3′, Roe1 reverse:
5′-GCCACGCGTATGGTACAAAT-3′; or63a forward: 5′-TG
GAACAAGCCACATCTGAG-3′, or63a reverse: 5′-TGTTAA
CCTCGGTTGCAAAGT-3′; NFAT forward: 5′-ACACAATC
CACGCCCAAG-3′, NFAT reverse: 5′-GAGCCACTCGCA
TTGGAC-3′; MTK forward: 5′-CCACCGAGCTAAGATGCA
A-3′, MTK reverse: 5′-TCTGCCAGCACTGATGTAGC-3′;
CTCF forward: 5′-GCTACACGTTCCGTGGTCA-3′, CTCF
reverse: 5′-CGCTTTCGGTGTCGATTT-3′; CG9935 forward:
5′-GCAGACACTGGAACAATCACA-3′, CG9935 reverse:
5′-GGACCTGTCAGACCTTTCCA-3′; CG6656 forward: 5′-
CGACCGATTGCAAAACATAA-3′, CG6656 reverse: 5′-C
AACCCAGAACGACACACAC-3′; CG30104 forward: 5′-CA
TGGATGTGGAGTTCAACG-3′, CG30104 reverse: 5′-GA
TGCCCTGTGCCTTCAG-3′; CG18343 forward: 5′-ACGCA
ATACTTTTCGGCTTC-3′, CG18343 reverse: 5′-AGGGCGA
TAACCACTTTGAG-3′; CG12428 forward: 5′-CGCAA
GTTCAACGACATTTTC-3′, CG12428 reverse: 5′-TTCATA
GCTTGGATTCCTTG-3′; CG11893 forward: 5′-CTGGAA
TGGACAACTTTTTGAA-3′, CG11893 reverse: 5′-TTCTC
AAAGTGTGGCTTGTACTTT-3′; 312 forward: 5′-TGGA
TCACTATTACGGCCTCA-3′, 312 reverse: 5′-GTCGTCCA
CATTCTCCTTGC-3′; DsRed forward: 5′-CCTCCTCCGA
GAACGTCATC-3′, DsRed reverse: 5′-CCCTCCATGCGCA
CCTT-3′.
Histochemistry and image quantiﬁcation
Cryosections were performed as described (48). For immunos-
taining, the primary antibody was anti-Hsc70/Hsp70
(SPA-822, 1:200, Stressgen-Enzo Life Sciences, Farmingdale,
NY). The secondary antibody was anti-mouse conjugated to
Human Molecular Genetics, 2011, Vol. 20, No. 24 4819Alexa Fluor 488 (1:100, Molecular Probes, Eugene, OR). The
number of Hsc70/Hsp70-positive particles was quantitated
using the particle analysis method implemented in Image J
(NIH). The thresholds were adjusted based on background
signals in the central brain region. Images from three to four
animals per genotype were analysed.
Climbing assay
Flies expressing the repeat gene by da-GAL4 were raised at
208C to prevent lethality at pre-adult stages and shifted to
298C after 1 day for a stronger effect and for time considerations.
About 8–20 female ﬂies were anaesthetized by CO2 and placed
in a plastic vial. After a 1 h recovery period, ﬂies were banged to
the bottom of the vial, and then the number of ﬂies that climbed
higher than a 2 cm threshold in 10 s was scored. Three trials
were performed at 5 min intervals for each cohort of animals.
At least, 100 ﬂies per genotype were examined in each repeat.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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